摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2,5-Dimethyl-phenoxy)-2-ethyl-pentanoic acid ethyl ester | 443924-72-9

中文名称
——
中文别名
——
英文名称
5-(2,5-Dimethyl-phenoxy)-2-ethyl-pentanoic acid ethyl ester
英文别名
——
5-(2,5-Dimethyl-phenoxy)-2-ethyl-pentanoic acid ethyl ester化学式
CAS
443924-72-9
化学式
C17H26O3
mdl
——
分子量
278.392
InChiKey
HKNMFFPQCNTGSN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.05
  • 重原子数:
    20.0
  • 可旋转键数:
    8.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    35.53
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and antiplatelet activity of gemfibrozil chiral analogues
    摘要:
    The chiral analogues of gemfibrozil 5-(2.5-dimethylphenoxy)-2-methylpentanoic acid and 5-(2,5-dimethylphenoxy)-2-ethylpentanoic acid were synthesized in optically active form using (S)-4-(1-methylethyl)-2-oxazolidinone as chiral auxiliary. All compounds inhibit human platelet aggregation. from these data. one can surmise that all tested compounds and gemfibrozil act at the platelet level with different mechanism than that of ASA, even if with a different potency. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00021-5
  • 作为产物:
    参考文献:
    名称:
    Synthesis and antiplatelet activity of gemfibrozil chiral analogues
    摘要:
    The chiral analogues of gemfibrozil 5-(2.5-dimethylphenoxy)-2-methylpentanoic acid and 5-(2,5-dimethylphenoxy)-2-ethylpentanoic acid were synthesized in optically active form using (S)-4-(1-methylethyl)-2-oxazolidinone as chiral auxiliary. All compounds inhibit human platelet aggregation. from these data. one can surmise that all tested compounds and gemfibrozil act at the platelet level with different mechanism than that of ASA, even if with a different potency. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00021-5
点击查看最新优质反应信息